Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Enterprise Value: -181.28M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | -181.28M |
| November 21, 2024 | -179.63M |
| November 20, 2024 | -168.09M |
| November 19, 2024 | -165.62M |
| November 18, 2024 | -161.49M |
| November 15, 2024 | -149.95M |
| November 14, 2024 | -103.77M |
| November 13, 2024 | -61.72M |
| November 12, 2024 | -51.82M |
| November 11, 2024 | -25.44M |
| November 08, 2024 | -27.08M |
| November 07, 2024 | -45.23M |
| November 06, 2024 | -47.14M |
| November 05, 2024 | -71.86M |
| November 04, 2024 | -84.22M |
| November 01, 2024 | -95.75M |
| October 31, 2024 | -120.47M |
| October 30, 2024 | -94.93M |
| October 29, 2024 | -95.75M |
| October 28, 2024 | -93.28M |
| October 25, 2024 | -103.99M |
| October 24, 2024 | -103.17M |
| October 23, 2024 | -99.87M |
| October 22, 2024 | -97.40M |
| October 21, 2024 | -88.33M |
| Date | Value |
|---|---|
| October 18, 2024 | -80.92M |
| October 17, 2024 | -82.57M |
| October 16, 2024 | -77.62M |
| October 15, 2024 | -72.68M |
| October 14, 2024 | -72.68M |
| October 11, 2024 | -75.98M |
| October 10, 2024 | -115.53M |
| October 09, 2024 | -103.17M |
| October 08, 2024 | -98.22M |
| October 07, 2024 | -95.75M |
| October 04, 2024 | -90.81M |
| October 03, 2024 | -97.40M |
| October 02, 2024 | -99.05M |
| October 01, 2024 | -99.87M |
| September 30, 2024 | -103.17M |
| September 27, 2024 | -139.12M |
| September 26, 2024 | -140.76M |
| September 25, 2024 | -153.87M |
| September 24, 2024 | -147.32M |
| September 23, 2024 | -131.74M |
| September 20, 2024 | -116.99M |
| September 19, 2024 | -104.69M |
| September 18, 2024 | -102.24M |
| September 17, 2024 | -97.32M |
| September 16, 2024 | -122.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-221.84M
Minimum
Nov 13 2023
916.42M
Maximum
Jan 22 2021
183.09M
Average
103.80M
Median
Apr 27 2022
Enterprise Value Benchmarks
| Fulcrum Therapeutics Inc | -81.93M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -48.79M |
| Revenue (Quarterly) | 8.52M |
| Total Expenses (Quarterly) | 76.44M |
| EPS Diluted (Quarterly) | -0.59 |
| Profit Margin (Quarterly) | -572.6% |
| Earnings Yield | -64.14% |
| Normalized Earnings Yield | -71.81 |